Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz Thomas and Láng István and Kahán Zsuzsanna and Greil R. and Beslija Semir and Stemmer Salomon M. and Kaufman B. and Petruzelka L. and Eniu A. and Anghel Rodica and Koynov K. and Vrbanec Damir and Pieńkowski Tadeusz and Melichar B. and Spanik S. and Ahlers S. and Messinger Diethelm and Inbar Moshe J. and Zielinski Christoph: Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11). pp. 2051-2057. ISSN 0007-0920 (2014)

[thumbnail of bjc2014504a.pdf]
Preview
Text
bjc2014504a.pdf - Published Version

Download (203kB) | Preview
Item Type: Journal Article
Journal or Publication Title: BRITISH JOURNAL OF CANCER
Date: 2014
Volume: 111
Number: 11
Page Range: pp. 2051-2057
ISSN: 0007-0920
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 2776321
DOI azonosító: https://doi.org/10.1038/bjc.2014.504
Date Deposited: 2017. Sep. 18. 09:49
Last Modified: 2020. Feb. 12. 12:40
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11951
Web of Science® Times Cited: 24 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year